Navigation Links
Elbit Imaging Ltd. Announces First Quarter Results for 2008
Date:5/29/2008

- (7,695) 6,698 (997)

Differences from translation of

foreign entities' financial

statements - (24,150) (4,692) (28,843)

Dividend paid - - - -

issuance of shares to the

minority by a subsidiary - - 61 61

Repayment of loans as a result of

the realization by employees of

rights to shares 957 957 - 957

Change in fair value of Swap

transactions - (1,946) - (1,946)

Stock based compensation expenses - 886 3,445 4,331

Premium of the minority in a

subsidiary - - 1,114 1,114

Employee share premium (5) - - -

March 31, 2008 0 540,930 342,558 883,488


'/>"/>
SOURCE Elbit Imaging Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
2. Elbit Medical Imaging Ltd. Announces Adjournment of its Annual General Meeting
3. Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing
4. Elbit Imaging Ltd. Selected for Listing on Nasdaq Global Select Market
5. Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes
6. Brain imaging reveals breakdown of normal emotional processing
7. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
8. Fry Construction Selected for High-Profile Medical Imaging Project
9. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
10. Imaging Software Helps Track, Treat Injured Brains
11. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... ... InventHelp, a leading inventor service company, announces that one of its ... to apply lotion or medication to a hard-to-reach area. This invention is patented. , ... to the back, and provides thorough coverage. The product would prevent the user from ...
(Date:7/30/2015)... ... July 30, 2015 , ... After conducting a nationwide executive search led ... Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh as Chief Executive ... years of healthcare leadership experience, Walsh is an expert in organizational change, physician development, ...
(Date:7/30/2015)... ... 30, 2015 , ... According to Chicago Implant Dentist Dr. ... removable denture acceptable. The demand for dental implants is rising exponentially and is ... loading techniques will have the ability to offer the patient a great service. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Diagnotes, Inc. announced ... for reimbursement from the Centers for Medicare & Medicaid Services (CMS) for the ... experimenting with manual data capture or, in many cases, just deciding it’s too ...
(Date:7/29/2015)... (PRWEB) , ... July 30, 2015 , ... Avid collector, ... Dorton Arena Raleigh North Carolina concert posters. The same poster art was used for ... by Globe Poster based in Baltimore and are classic boxing style concert posters. ...
Breaking Medicine News(10 mins):Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 2Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 3
... NY, May 5, 2011When children or adolescents with asthma ... it may impair their ability to manage the asthma ... is described in an article in Pediatric Allergy, ... Mary Ann Liebert, Inc. The article is available free ...
... cells have huge potential in medicine because they have the ... (such as nerve cells, muscle cells, and skin cells)potentially providing ... permanently lost by a patient. Stem cells are also relevant ... processes that shape the formation of one cell type versus ...
... News) -- The makers of cold and fever medications that ... discontinue infant-drops versions of the products to avoid confusion that ... Once production ends, later this year, the companies will ... of 12. Companies such as Johnson & Johnson currently sell ...
... [Brown University] Despite evidence that feeding tubes do ... elderly patients with advanced dementia, their frequency of use ... family members finds that discussions surrounding the decision to ... dementia is a terminal illness that often affects a ...
... 5, 2011 Ben-Gurion University of the Negev researcher ... from the Bill & Melinda Gates Foundation to develop ... without the need for blood collection in field settings. ... cellphone and a red laser pointer that can noninvasively ...
... modifications present in breast cancer has revealed potentially important ... researchers have reported. Epigenetics is a term used ... way its code is translated into proteins. These changes ... researchers knew epigenetics was important in cancer, information about ...
Cached Medicine News:Health News:CIRM awards Scripps Research Institute scientists $3.5 million 2Health News:Drugmakers to End Infant Formulas of Products With Acetaminophen 2Health News:Drugmakers to End Infant Formulas of Products With Acetaminophen 3Health News:Families need to know more about feeding tubes for elderly dementia patients 2Health News:Gates Foundation awards Ben-Gurion U. researcher grant for malaria detection using cell phones 2Health News:Epigenetic study reveals new insights into breast cancer 2Health News:Epigenetic study reveals new insights into breast cancer 3
(Date:7/29/2015)... DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... June 30, 2015. For the second quarter of 2015, the Company ... share, compared to a net loss of $13.4 million, or $0.18 ... six months ended June 30, 2015, the Company reported a net ... to net loss of $25.2 million, or $0.35 loss per share, ...
(Date:7/29/2015)... 29, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... Board of Directors, after careful consideration and with ... advisors, has unanimously rejected the purported revised, highly ... plc (NASDAQ: HZNP ) ("Horizon") to acquire ... an all-stock transaction (the "July 21 Proposal"). ...
(Date:7/29/2015)... The U.S. Food and Drug Administration (FDA) ... Integrated Dual Balloon System, that may help fill a ... obesity and one or more obesity-related conditions, according to ... the nation,s largest organization for bariatric surgeons. ... the FDA has approved this new device for the ...
Breaking Medicine Technology:Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3
... /PRNewswire-FirstCall/ --,Wyeth Pharmaceuticals, a division of Wyeth ... clinical study,results on bifeprunox at an international ... an investigational,treatment for adult patients diagnosed with ... lipid profile, similar to,placebo. In addition, increases ...
... 30, 2007 /PRNewswire-FirstCall/ - Helix today,announced positive results ... Interferon Alpha-2b in women with human papilloma virus,(HPV) ... a clinically efficacious response to treatment,in nearly half ... an excellent safety profile, with no significant local,intolerance ...
Cached Medicine Technology:Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 2Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 3Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 4Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 6Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 2Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 3Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 4Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 5Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 6
Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease...
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
... D kit is an enzymeimmunoassay for the ... metabolites in serum or plasma. Calibrators, controls ... 25-OH D. The diluted samples are incubated ... a highly specific sheep 25-OH D antibody ...
Medicine Products: